Effects of RG7652, a Monoclonal Antibody Against PCSK9, on LDL-C, LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or With Established Coronary Heart Disease (from the Phase 2 EQUATOR Study)

Amos Baruch, Sofia Mosesova, John D. Davis, Nageshwar Budha, Alexandr Vilimovskij, Robert S. Kahn, Kun Peng, Kyra J. Cowan, Laura Harris, Thomas Gelzleichter,

The American Journal of Cardiology · 2017 · 55 citations · 22 references

Concepts

References

22